ESC 365 - New therapies for HFrEF: omecamtiv mecarbil.

ESC Premium Access

New therapies for HFrEF: omecamtiv mecarbil.

Session: Hot off the press: latest updates on new therapeutic approaches to HFrEF

Topic: Chronic Heart Failure

Speaker: Professor J. Teerlink (San Francisco, US)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Professor John R Teerlink

San Francisco Veterans Affairs Medical Centre, San Francisco (United States of America)

35 presentations

0 follower

3 more presentations in this session

New therapies for HFrEF: vericiguat.

Speaker: Professor B. Pieske (Rostock, DE)

New therapies for HFrEF: intravenous iron.

Speaker: Professor E. Jankowska (Wroclaw, PL)

Hot off the press: latest updates on new therapeutic approaches to HFrEF – discussion.

Access the full session

Hot off the press: latest updates on new therapeutic approaches to HFrEF

Speakers: Professor J. Teerlink, Professor B. Pieske, Professor E. Jankowska

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources